Filtered By:
Source: American Heart Journal
Condition: Diabetes Type 2
Management: Healthcare Costs
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1 results found since Jan 2013.
Ischemic Cardiac Outcomes and Hospitalizations According to Prior Macrovascular Disease Status in Patients with Type 2 Diabetes and Recent Acute Coronary Syndrome from the EXAMINE trial
Conclusions EXAMINE demonstrates that there was no increase in the risk of cardiac ischemic events and cardiovascular hospitalizations with alogliptin in a high-risk post-ACS patient population. Since these are major driver of overall healthcare costs, these data suggest that there would be no adverse impact on healthcare resource utilization.
Source: American Heart Journal - January 25, 2016 Category: Cardiology Source Type: research
